TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Europe Ophthalmic Devices & Drugs market was valued at US$ 12.4 billion in 2024 and is projected to reach US$ 18.9 billion by 2030, at a CAGR of 7.3% during the forecast period 2024-2030.
Comprehensive range of medical devices and pharmaceuticals for eye care, including diagnostic equipment, surgical tools, and therapeutic medications.
Medical sector leads 100%. Germany dominates 35%. Innovation in devices 75%. Drug development 62%. Treatment efficacy improving. Technology integration increasing. Patient care advancing. Market expansion continuing.
Report Includes
This report is an essential reference for who looks for detailed information on Europe Ophthalmic Devices & Drugs. The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendors¡¯ information. In addition to the data part, the report also provides overview of Ophthalmic Devices & Drugs, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Europe Ophthalmic Devices & Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Devices & Drugs. This report contains market size and forecasts of Ophthalmic Devices & Drugs in Europe, including the following market information:
We surveyed the Ophthalmic Devices & Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• Germany
• United Kingdom
• France
• Italy
• Spain
• Netherlands
• Belgium
• Ophthalmic Devices
• Ophthalmic Drugs
• Glaucoma
• Cataract
• Age-Related Macular Degeneration
• Inflammatory Diseases
• Refractive Disorders
• Alcon
• Carl Zeiss Meditec AG
• Essilor
• Bausch Health Companies Inc.
• Novartis AG
• HOYA Corporation
• Topcon Corporation
• NIDEK CO., LTD.
• ZEISS Group
• Santen Pharmaceutical Co., Ltd.
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies Ophthalmic Devices & Drugs revenues in Europe market, 2019-2024 (Estimated), ($ millions)
• Key companies Ophthalmic Devices & Drugs revenues share in Europe market, 2023 (%)
• Key companies Ophthalmic Devices & Drugs sales in Europe market, 2019-2024 (Estimated),
• Key companies Ophthalmic Devices & Drugs sales share in Europe market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Europe and country-wise market of Ophthalmic Devices & Drugs
• It describes present situation, historical background and future forecast
• Comprehensive data showing Ophthalmic Devices & Drugs capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Ophthalmic Devices & Drugs manufacturers
• Ophthalmic Devices & Drugs forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
1.1 Product Overview and Scope of Ophthalmic Devices & Drugs
1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Ophthalmic Devices
1.2.3 Ophthalmic Drugs
1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Glaucoma
1.3.3 Cataract
1.3.4 Age-Related Macular Degeneration
1.3.5 Inflammatory Diseases
1.3.6 Refractive Disorders
1.4 Europe Market Growth Prospects
1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)
1.4.2 Europe Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Europe Production by Manufacturers (2019-2023)
3.2 Europe Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Europe Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Europe 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Europe Production
4.1.1 Europe Production YoY Growth Rate (2019-2023)
4.1.2 Europe Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Europe
5.1.1 Europe Consumption by Country
5.1.2 Europe Sales, Consumption, Export, Import (2019-2023)
5.1.1 Germany
5.2.2 United Kingdom
5.3.3 France
5.4.4 Italy
5.5.5 Spain
5.6.6 Netherlands
5.7.7 Belgium
6.1 Europe Production Market Share by Type (2019-2024)
6.2 Europe Revenue Market Share by Type (2019-2024)
6.3 Europe Price by Type (2019-2024)
7.1 Europe Production Market Share by Application (2019-2024)
7.2 Europe Revenue Market Share by Application (2019-2024)
7.3 Europe Price by Application (2019-2024)
8.1 Alcon
8.1.1 Alcon Corporation Information
8.1.2 Alcon Product Portfolio
8.1.3 Alcon Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Alcon Main Business and Markets Served
8.1.5 Alcon Recent Developments/Updates
8.2 Carl Zeiss Meditec AG
8.2.1 Carl Zeiss Meditec AG Corporation Information
8.2.2 Carl Zeiss Meditec AG Product Portfolio
8.2.3 Carl Zeiss Meditec AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Carl Zeiss Meditec AG Main Business and Markets Served
8.2.5 Carl Zeiss Meditec AG Recent Developments/Updates
8.3 Essilor
8.3.1 Essilor Corporation Information
8.3.2 Essilor Product Portfolio
8.3.3 Essilor Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Essilor Main Business and Markets Served
8.3.5 Essilor Recent Developments/Updates
8.4 Bausch Health Companies Inc.
8.4.1 Bausch Health Companies Inc. Corporation Information
8.4.2 Bausch Health Companies Inc. Product Portfolio
8.4.3 Bausch Health Companies Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Bausch Health Companies Inc. Main Business and Markets Served
8.4.5 Bausch Health Companies Inc. Recent Developments/Updates
8.5 Novartis AG
8.5.1 Novartis AG Corporation Information
8.5.2 Novartis AG Product Portfolio
8.5.3 Novartis AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Novartis AG Main Business and Markets Served
8.5.5 Novartis AG Recent Developments/Updates
8.6 HOYA Corporation
8.6.1 HOYA Corporation Corporation Information
8.6.2 HOYA Corporation Product Portfolio
8.6.3 HOYA Corporation Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 HOYA Corporation Main Business and Markets Served
8.6.5 HOYA Corporation Recent Developments/Updates
8.7 Topcon Corporation
8.7.1 Topcon Corporation Corporation Information
8.7.2 Topcon Corporation Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Topcon Corporation Main Business and Markets Served
8.7.4 Topcon Corporation Recent Developments/Updates
8.8 NIDEK CO., LTD.
8.8.1 NIDEK CO., LTD. Corporation Information
8.8.2 NIDEK CO., LTD. Product Portfolio
8.8.3 NIDEK CO., LTD. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 NIDEK CO., LTD. Main Business and Markets Served
8.8.5 NIDEK CO., LTD. Recent Developments/Updates
8.9 ZEISS Group
8.9.1 ZEISS Group Corporation Information
8.9.2 ZEISS Group Product Portfolio
8.9.3 ZEISS Group Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 ZEISS Group Main Business and Markets Served
8.9.5 ZEISS Group Recent Developments/Updates
8.10 Santen Pharmaceutical Co., Ltd.
8.10.1 Santen Pharmaceutical Co., Ltd. Corporation Information
8.10.2 Santen Pharmaceutical Co., Ltd. Product Portfolio
8.10.3 Santen Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Santen Pharmaceutical Co., Ltd. Main Business and Markets Served
8.10.5 Santen Pharmaceutical Co., Ltd. Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Ophthalmic Devices & Drugs
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Europe Production, Revenue Forecast (2024-2030)
13.1 Europe Forecasted Consumption of by Country
14.1 Europe Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Europe Forecasted Production of by Type (2024-2030)
14.1.2 Europe Forecasted Revenue of by Type (2024-2030)
14.1.3 Europe Forecasted Price of by Type (2024-2030)
14.2 Europe Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Europe Forecasted Production of by Application (2024-2030)
14.2.2 Europe Forecasted Revenue of by Application (2024-2030)
14.2.3 Europe Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
